Abstract 3973: Nivolumab-based ELISA revealed increased serum PD-1 levels in advanced RCC patients
Sign Up to like & getrecommendations! Published in 2019 at "Immunology"
DOI: 10.1158/1538-7445.am2019-3973
Abstract: Introduction: Antibody therapy has been successfully used for several caners, but the efficacy is still limited. To select patients that respond well to the therapy, development of companion diagnostics is essential. Although PD-L1 expression determined… read more here.
Keywords: rcc patients; nivolumab based; antibody; serum levels ... See more keywords